Advertisements

PARIS — France has canceled its order for Merck & Co’s COVID-19 antiviral drug following disappointing trial data and hopes instead to receive Pfizer’s competing drug before the end of January, the health minister said on Wednesday. Read More

Daily Digest Signup

Daily business and market business news, business management tips, market research insights, and more.

Advertisements

Smart public opinion research for everyone.

Generated by Feedzy
%d bloggers like this: